Gujarat Kidney and Super Speciality Limited IPO Proceeds Utilization Report
Gujarat Kidney and Super Speciality Ltd 路 Others (Uncategorized) 路 05 Nov 2026, 1:25 am
Gujarat Kidney and Super Speciality Limited IPO Proceeds Utilization Report Brickwork Ratings released its Monitoring Agency Report for Gujarat Kidney and Super Speciality Limited for the quarter ended 30th Sep'26, tracking proceeds from its Rs 250.80 crore fresh issue. Key deployments include Parekhs Hospital acquisition (Rs 77.00 crore), inorganic growth/general corporate purposes (Rs 87.43 crore), and a 51% stake acquisition in Blue Tree Clinics LLC, Dubai (Rs 7.23 crore). As of quarter-end, remaining unutilized proceeds totaled Rs 19.28 crore, held across HDFC Bank accounts and fixed deposits yielding 5.75%, with zero deviations reported from stated objects.
Original exchange filing (PDF)
More announcements from Gujarat Kidney and Super Speciality Ltd
- Transcript of Earning Call conducted on 05/11/2026 路 11 Nov 2026
- Audio recording of earning call 路 05 Nov 2026
- Revised presentation Uploaded for today''s Earning Con-Call. 路 05 Nov 2026
- Investor Presentation for scheduled Conference Call on November 05, 2026 路 05 Nov 2026
- Statement of Deviation and Variation submitted for the quarter ended on September 30, 2026. 路 05 Nov 2026
- Unaudited Standalone and Consolidated Financial Results for the Quarter ended September 30, 2026 路 05 Nov 2026
- Gujarat Kidney And Super Speciality Limited has submitted to the Exchange, the unaudited Standalone and Consolidated financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Earning Con-call 路 05 Nov 2026
